1. Home
  2. IFRX vs YDDL Comparison

IFRX vs YDDL Comparison

Compare IFRX & YDDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$2.00

Market Cap

303.4M

Sector

Health Care

ML Signal

HOLD

YDDL

One and One Green Technologies. Inc Class A Ordinary Shares

N/A

Current Price

$1.74

Market Cap

358.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
IFRX
YDDL
Founded
2007
2014
Country
Germany
Philippines
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
303.4M
358.9M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
IFRX
YDDL
Price
$2.00
$1.74
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
824.4K
11.0K
Earning Date
05-07-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$40.85
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$1.65
52 Week High
$2.95
$16.23

Technical Indicators

Market Signals
Indicator
IFRX
YDDL
Relative Strength Index (RSI) 58.96 37.98
Support Level $1.58 $1.65
Resistance Level $2.94 $1.93
Average True Range (ATR) 0.12 0.09
MACD 0.04 0.04
Stochastic Oscillator 85.06 44.44

Price Performance

Historical Comparison
IFRX
YDDL

About IFRX InflaRx N.V.

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About YDDL One and One Green Technologies. Inc Class A Ordinary Shares

One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.

Share on Social Networks: